跳至主要内容
临床试验/IRCT20191006044994N1
IRCT20191006044994N1招募中2 期

Comparison of the effect of Rosa damascena with placebo on liver enzymes in patients with nonalcoholic fatty liver disease(NAFLD): a double-blind randomized clinical trial

Iran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Sonographic report of Grade 1- 2-3 fatty liver
  • Increase in ALT> 38? Increase in AST>31 Ages 12 to 80 years
  • Ages 18 to 80 years

排除标准

  • The patient's unwillingness to participate in the scheme
  • Pregnancy & lactation
  • Anti coagulant drugs consumption
  • Thyroid diseases
  • Spleen diseases
  • Cirrhosis ,viral hepatitis and obstructive liver disese
  • Treated dyslipidemia
  • Overt Diabetes mellitus
  • Lung diseases
  • Taking any medication that affects liver metabolism and enzymes, including oral contraceptives, corticosteroids, salazines, etc.

研究者

相似试验